GO:0070603 SWI/SNF superfamily-type complex

The SWI/SNF superfamily-type complex (GO:0070603) is a cellular-component ontology term that defines a class of ATP-dependent chromatin remodeling machines. These complexes contain an ortholog of the Saccharomyces cerevisiae ATPase Swi2/Snf2 as their catalytic subunit and mediate nucleosome assembly, changes in nucleosome spacing or structure, or a combination of these activities in an ATP-dependent manner. Because they directly control DNA accessibility, SWI/SNF complexes are central regulators of transcription, DNA repair, and replication. In human cells, the catalytic ATPase is typically SMARCA4 (BRG1) or SMARCA2 (BRM), and mutations in these subunits are widespread across malignancies. Pan-cancer analyses have shown that SMARCA4 alterations occur in a broad spectrum of tumor types, underscoring the clinical importance of this complex. Beyond cancer, SWI/SNF components have been detected in extracellular vesicle RNA landscapes from human mesenchymal stromal cells, suggesting roles in intercellular communication and broader cell biology. In small-cell lung carcinoma and large-cell neuroendocrine lung carcinoma, weighted gene co-expression network analysis of clinical tissue proteomes identified SWI/SNF-related modules as key hub components, linking this complex to aggressive neuroendocrine tumors. For researchers, GO:0070603 provides a precise ontological handle for studying how ATP-dependent nucleosome remodeling shapes gene expression programs in health and disease [1,3].

GO:0070603, the SWI/SNF superfamily-type complex, is defined in QuickGO as a protein complex that contains an ortholog of the Saccharomyces ATPase Swi2/Snf2 as one of its catalytic subunit components (ATPase) and mediates assembly of nucleosomes, changes to the spacing or structure of nucleosomes, or some combination of those activities in a manner that requires ATP. In simpler terms, it is a molecular machine that burns ATP to slide, eject, or reorganize nucleosomes, thereby opening or closing chromatin for gene regulation.

GO:0070603 is important because ATP-dependent chromatin remodeling by SWI/SNF superfamily complexes controls essentially all DNA-templated processes, including transcription, replication, and repair. Dysregulation of these complexes, particularly through mutations in the catalytic subunit SMARCA4, is a recurrent event in human cancer and is associated with aggressive tumor phenotypes. In neuroendocrine lung tumors, SWI/SNF-related modules emerge as key hub components in co-expression networks, highlighting their role in tumor biology. Understanding this complex therefore has direct implications for cancer diagnostics, prognostics, and therapeutic targeting [1,3].

The following genes encode subunits or associated components of SWI/SNF superfamily-type complexes (GO:0070603) and are recurrently studied in cancer and chromatin biology [1,3].

SWI/SNF superfamily-type complexes are regulated at multiple levels, including subunit expression, post-translational modifications, and interaction with transcription factors. In cancer, mutations in SMARCA4 and other subunits alter complex activity and targeting, leading to changes in chromatin accessibility and gene expression. Co-expression network analyses in neuroendocrine lung tumors have identified SWI/SNF-related modules as key hubs, suggesting that their expression is coordinated with broader transcriptional programs. Additionally, SWI/SNF components can be detected in extracellular vesicle RNA landscapes, indicating potential regulation through intercellular communication.

Pan-cancer analysis of SMARCA4 alterations has revealed that mutations, deletions, and amplifications occur across a wide range of human cancers. These alterations can lead to loss of ATP-dependent chromatin remodeling activity, resulting in aberrant gene expression and tumor progression. SMARCA4-mutant cancers often depend on the residual SMARCA2 subunit, creating a synthetic lethal vulnerability.

Weighted gene co-expression network analysis of clinical tissue proteomes from small-cell lung carcinoma and large-cell neuroendocrine lung carcinoma identified key modules and hub genes, including SWI/SNF-related components. These findings suggest that SWI/SNF superfamily-type complexes contribute to the molecular pathology of aggressive neuroendocrine lung tumors.

SWI/SNF complex components have been detected in the long noncoding RNA landscape of small extracellular vesicles derived from human mesenchymal stromal cells. This observation suggests that SWI/SNF-related RNAs may be packaged into extracellular vesicles and potentially influence recipient cells.

CRISPR knockout, point-mutation, knock-in, and overexpression models enable precise dissection of SWI/SNF subunit functions. These approaches can reveal whether a specific mutation in SMARCA4 or other subunits is causally linked to cancer phenotypes.

Weighted gene co-expression network analysis of clinical tissue proteomes can identify key modules and hub genes, including SWI/SNF-related components, in diseases such as small-cell lung carcinoma and large-cell neuroendocrine lung carcinoma.

Long noncoding RNA landscapes of small extracellular vesicles derived from human mesenchymal stromal cells can reveal SWI/SNF-related transcripts, providing insights into intercellular communication.

ATAC-seq and related methods measure changes in chromatin accessibility following perturbation of SWI/SNF superfamily-type complexes, linking remodeling activity to gene expression.

Researchers studying SWI/SNF superfamily-type complex-related genes often need to determine whether a candidate gene is causally involved in chromatin remodeling, tumorigenesis, or neuroendocrine lung cancer biology. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such functional studies.

GO:0070603, the SWI/SNF superfamily-type complex, represents a critical class of ATP-dependent chromatin remodeling machines that control DNA accessibility and gene expression. Its subunits, particularly SMARCA4, are recurrently altered in human cancers, and SWI/SNF-related modules are key hubs in neuroendocrine lung tumor networks [1,3]. Understanding the assembly, regulation, and disease roles of this complex requires robust experimental models, including CRISPR knockout, point-mutation, knock-in, and overexpression systems. EDITGENE provides comprehensive services to support such research, from custom cell model generation to CRISPR library screening and bioinformatics analysis.